| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 04/16/2003 | EP1301466A2 7-substituted tetracycline compounds |
| 04/16/2003 | EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/16/2003 | EP0972769B1 Novel amide derivatives and medicinal compositions thereof |
| 04/16/2003 | EP0649414B1 Opioid diarylmethylpiperazines and piperidines |
| 04/16/2003 | CN1411453A Trans olefinic glucokinase activators |
| 04/16/2003 | CN1411451A Method for production of 1,3-disubstituted 2-nitroguanidines |
| 04/16/2003 | CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 04/16/2003 | CN1411435A Novel use of phenyl hetero alkylamine derivatives |
| 04/16/2003 | CN1410418A Derivative containing alkyl sulfanyl hydrazone having insecticidal, antibacterial and herbicidal activity and its preparation method |
| 04/16/2003 | CN1105718C Improved method for producing thiazolidinediones, and new thiazolidinediones |
| 04/15/2003 | US6548676 Halogenation or sulfonylation of 5-methylol-2-sulfanyl-thiazole derivatives; separation, salt formation |
| 04/15/2003 | US6548667 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase |
| 04/15/2003 | US6548481 A salt form of a dipeptide compound formed from an amino acid and a thiazolidine or pyrrolidine group, and the salts are selected from acetates, tartrates, fumarates, succinates, phosphates and sulfates |
| 04/10/2003 | WO2003029231A1 Nematicidal trifluorobutene derivatives |
| 04/10/2003 | WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003028650A2 Benzimidazolidinone derivatives as muscarinic agents |
| 04/10/2003 | WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 04/10/2003 | US20030069292 Central nervous system disorders; anticonvulsants |
| 04/10/2003 | US20030069284 Anticancer agent |
| 04/10/2003 | US20030069277 Anticancer agents |
| 04/10/2003 | US20030069275 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 04/10/2003 | US20030069242 3-arylphenyl sulfide derivative and insecticide and miticide |
| 04/10/2003 | US20030069238 Anticancer agents; immunology diseases; antiallergens; antiinflammatory agents |
| 04/10/2003 | US20030069233 Central nervous system disorders; psychological disorders; Alzheimer's disease |
| 04/10/2003 | US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses. |
| 04/10/2003 | US20030066988 Electroconductivity coloring |
| 04/10/2003 | CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | CA2457647A1 Benzimidazolidinone derivatives as muscarinic agents |
| 04/09/2003 | EP1300401A1 Five-membered-ring compound |
| 04/09/2003 | EP1300398A1 Propane-1,3-dione derivatives |
| 04/09/2003 | EP1299365A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299359A1 Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
| 04/09/2003 | EP1299354A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 04/09/2003 | EP1299352A2 Compounds to treat alzheimer's disease |
| 04/09/2003 | EP1299349A2 Compounds to treat alzheimer's disease |
| 04/09/2003 | EP1299103A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299102A2 Use of riluzole or its salts for preventing and treating adrenoleukodystrophy |
| 04/09/2003 | EP0946528B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 04/09/2003 | EP0724439B1 Use of 2-(2alkylphenylamino)oxazolines and -thiazolines for the manufacture of a medicament with alpha 2 adrenergic effect |
| 04/09/2003 | CN1409715A Cyclopenteneone derivatives |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/09/2003 | CN1105106C Naphthol derivatives and rpocess for preparation thereof |
| 04/08/2003 | US6545155 Fused heteroaromatic glucokinase activators |
| 04/08/2003 | US6545152 Viricides; polymerase enzyme inhibitor |
| 04/08/2003 | US6545026 Increase the transactivation of receptor as a ligand of human peroxisome proliferator-activated receptor and exhibit blood glucose-decreasing action and lipid-decreasing action |
| 04/08/2003 | US6545009 Retinoid-related receptor function regulating agent |
| 04/08/2003 | US6545003 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/08/2003 | US6544995 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G protein |
| 04/08/2003 | US6544931 For controlling plant growth |
| 04/08/2003 | US6544499 Polysiloxane or silicone resin, a linker, and a molecular hook for treating amino acid based substrates; hair care |
| 04/04/2003 | WO2002030896A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 04/04/2003 | CA2424979A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 04/03/2003 | WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/03/2003 | WO2003027081A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 04/03/2003 | WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/03/2003 | WO2003002530A3 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 04/03/2003 | US20030065191 Process for the preparation of thiazole derivatives |
| 04/03/2003 | US20030065176 Anticoagulant; cardiovascular disorders |
| 04/03/2003 | US20030065031 Glucagon antagonists/inverse agonists |
| 04/03/2003 | US20030065006 Viricides; anticancer agents |
| 04/03/2003 | US20030064977 Viricides |
| 04/03/2003 | US20030064972 Using thiazolidinone compound |
| 04/03/2003 | US20030064968 Viricides, anticarcinogneic agents |
| 04/03/2003 | CA2460541A1 Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer |
| 04/03/2003 | CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/02/2003 | EP1296979A1 Hetaryl-substituted heterocycles |
| 04/02/2003 | EP1296967A1 Quinolinyl and benzothiazolyl ppar-gamma modulators |
| 04/02/2003 | EP1296942A1 Glucagon antagonists/inverse agonists |
| 04/02/2003 | EP1296931A2 Polyamine analogues as cytotoxic agents |
| 04/02/2003 | EP1135126A4 Myt1 kinase inhibitors |
| 04/02/2003 | EP1121108B1 Novel therapeutic use of compounds with beta-3-agonist activity |
| 04/02/2003 | EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 04/02/2003 | EP0850231B1 Process for preparing a 2-chloro-5-chloromethyl-thiazole compound |
| 04/02/2003 | EP0741694B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
| 04/02/2003 | CN1406936A Herbicidal (4-Cl-2-O-benzothiazolyline-3-group) alkyl carboxylic ester compounds |
| 04/02/2003 | CN1104429C 4-(3-heterocycly-1-benzoyl) pyrazoles and their use as herbicides |
| 04/02/2003 | CN1104425C Heterocyclic thioethers as additives for lubricants |
| 04/02/2003 | CN1104422C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 04/02/2003 | CN1104413C Phenylalkylcarboxylic acid derivatives |
| 04/02/2003 | CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
| 04/02/2003 | CN1104241C Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetraphdropyridine for preparing drugs for treating amyotrophic lateral scherosis |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541496 Inhibitors of IMPDH enzyme |
| 04/01/2003 | US6541493 Type A, B, C and D crystals of said compound; excellent in stability, and has advantages in handling, storage, and pharmaceutical preparation. |
| 04/01/2003 | US6541492 Thiazole derivatives as PPAR gamma ligands |
| 04/01/2003 | US6541477 Inhibitors of p38-a kinase |
| 04/01/2003 | US6541475 2-nitrostyryl-1-(naphthylmethyl)sulfone for example |
| 04/01/2003 | US6541016 Monoalkyl phosphoric esters, dialkyl phosphoric esters, and, in small amounts, trialkyl phosphoric esters or salts, based on beta-branched fatty alcohols, effective in lowering the surface tension of both polar and nonpolar liquids |
| 04/01/2003 | CA2288439C Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/27/2003 | WO2003025017A1 Cytokine receptor |
| 03/27/2003 | WO2003024955A2 Small molecule inhibitors of caspases |
| 03/27/2003 | WO2003024943A2 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |